1 |
Agata, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H., and Honjo, T. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8, 765-772.
DOI
ScienceOn
|
2 |
Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., and Pinsky, M.R. 2001. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care. Med. 29, 1303-1310.
DOI
ScienceOn
|
3 |
Annane, D., Bellissant, E., and Cavailon, J.M. 2005. Septic shock. Lancet 365, 63-78.
DOI
ScienceOn
|
4 |
Azuma, M., Ito, D., Yagita, H., Okumura, K., Phillips, J.H., Lanier, L.L., and Somoza, C. 1993. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366, 76-79.
DOI
ScienceOn
|
5 |
Blanco, J.C., Contursi, C., Salkowski, C.A., DeWitt, D.L., Ozato, K., and Vogel, S.N. 2000. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J. Exp. Med. 191, 2131-2144.
DOI
ScienceOn
|
6 |
Carter, L., Fouser, L.A., Jussif, J., Fitz, L., Deng, B., Wood, C.R., Collins, M., Honjo, T., Freeman, G.J., and Carreno, B.M. 2002. PD-1: PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur. J. Immunol. 32, 634-643.
DOI
|
7 |
Cho, H.Y., Lee, S.W., Seo, S.K., Choi, I.W., Choi, I.h., and Lee, S.W. 2008. Interferon-sensitive response element (ISRE) is mainly responsible for IFN--induced upregulation of programmed death-1 (PD-1) in macrophages. Biochimi. Biophys. Acta 1779, 811-819.
DOI
ScienceOn
|
8 |
Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420, 885-891.
DOI
ScienceOn
|
9 |
Freeman, G.J., Freedman, A.S., Segil, J.M., Lee, G., Whitman, J.F., and Nadler, L.M. 1989. B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells. J. Immunol. 143, 2714-2722.
|
10 |
Freeman, G.J., Long, A.J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L.J., Malenkovich, N., Okazaki, T., Byrne, M.C., and et al. 2000. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034.
DOI
ScienceOn
|
11 |
Hsu, H.Y. and Wen, M.H. 2002. Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression. J. Biol. Chem. 277, 22131-22139.
DOI
ScienceOn
|
12 |
Huang, X., Venet, F., Wang, Y.L., Lepape, A., Yuan, Z., Chen, Y., Swan, R., Kherouf, H., Monneret, G., Chung, C.S., and et al. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc. Natl. Acad. Sci. USA 14, 6303-6308.
|
13 |
Ishida, Y., Agata, Y., Shibahara, K., and Honjo, T. 1992. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887-3895.
|
14 |
Jiang, Z., Georgel, P., Du, X., Shamel, L., Sovath, S., Mudd, S., Huber, M., Kalis, C., Keck, S., Galanos, C., and et al. 2005. CD14 is required for MyD88-independent LPS signaling. Nature Immunol. 6, 565-570.
DOI
ScienceOn
|
15 |
Judith, M.C., Linda, B., Thomas, J.G., William, C.C., and Gerard, M.D. 2005. Interferon regulatory factor 1 (IRF-1) and IRF-2 expression in breast cancer tissue microarrays. J. Interferon Cytokine Res. 25, 587-594.
DOI
ScienceOn
|
16 |
Keir, M.E., Francisco, L.M., and Sharpe, A.H. 2007. PD-1 and its ligands in T-cell immunity. Curr. Opin. Immunol. 19, 309-314.
DOI
ScienceOn
|
17 |
Lawrence, T., Gilroy, D.W., Colville-Nash, P.R., and Willoughby, D.A. 2001. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 7, 1291-1297.
DOI
ScienceOn
|
18 |
Kim, Y.H., Choi, M.R., Song, D.K., Huh, S.O., Jang, C.G., and Suh, H.W. 2000. Regulation of c-fos gene expression by lipopolysaccharide and cycloheximide in C6 rat glioma cells. Brain Res. 872, 227-230.
DOI
ScienceOn
|
19 |
Kou, X., Qi, S., Dai, W., Luo, L., and Yin, Z. 2011. Arctigenin inhibits lipopolysaccharide-induced iNOS expression in RAW264.7 cells through suppressing JAK-STAT signal pathway. Int. Immunopharmacol. 11, 1095-1102.
DOI
ScienceOn
|
20 |
Latchman, Y., Wood, C.R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A.J., Brown, J.A., Nunes, R., and et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2, 261-268.
DOI
ScienceOn
|
21 |
Martin, G.S., Mannino, D.M., Eaton, S., and Moss, M. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348, 1546-1554.
DOI
ScienceOn
|
22 |
Mueller, D.L., Jenkins, M.K., and Schwartz, R.H. 1989. Clonal expansion versus functional clonal inactivation: a costimulatory signaling pathway determines the outcome of T cell antigen receptor occupancy. Annu. Rev. Immunol. 7, 445-480.
DOI
ScienceOn
|
23 |
Nishimura, H., Minato, N., Nakano, T., and Honjo, T. 1998. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int. Immunol. 10, 1563-1572.
DOI
ScienceOn
|
24 |
Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T., and Honjo, T. 2001. PD-1 immunoreceptor inhibits B cell receptormediated signaling by recruiting src homology 2-domaincontaining tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 98, 13866-13871.
DOI
ScienceOn
|
25 |
Singh, A.K., Stock, P., and Akbari, O. 2011. Role of PD-L1 and PD-L2 in allergic diseases and asthma. Allergy 66, 155-162.
DOI
ScienceOn
|
26 |
Parant, M., Parant, F., and Chedid, L. 1977. Inheritance of lipopolysaccharide-enhanced nonspecific resistance to infection and of susceptibility to endotoxic shock in lipopolysaccharide low-responder mice. Infect. Immun. 16, 432-438.
|
27 |
Parry, R.V., Chemnitz, J.M., Frauwirth, K.A., Lanfranco, A.R., Braunstein, I., Kobayashi, S.V., Linsley, P.S., Thompson, C.B., and Riley, J.L. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell Biol. 25, 9543-9553.
DOI
ScienceOn
|
28 |
Salkowski, C.A., Kopydlowski, K., Blanco, J., Cody, M.J., McNally, R., and Vogel, S.N. 1999. IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163, 1529-1536.
|
29 |
Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H., Ruff, W., Broadwater, M., Choi, I.H., and et al. 2009. PD-1 on dendritic cells impedes innate immunity against bacterial infection. Blood 113, 5811-5818.
DOI
ScienceOn
|
30 |
Zhang, X., Schwartz, J.C., Guo, X., Bhatia, S., Cao, E., Lorenz, M., Cammer, M., Chen, L., Zhang, Z.Y., Edidin, M.A., and et al. 2004. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 20, 337-347.
DOI
ScienceOn
|